JEFF ALLEN was named the president and CEO of Friends of Cancer Research. Ellen Sigal, founder of Friends, will continue with the organization as board chair. Marlene Malek, former president of Friends, will become the vice-chair. Allen will lead the day-to-day scientific and policy programs and organizational operations at Friends. He will also direct strategic...
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
